American International Group, Inc. Abb Vie Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, American International Group, Inc. holds 453,514 shares of ABBV stock, worth $77.8 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

453,514

Previous 456,263 0.6%

Holding current value

$77.8 Million

Previous $70.7 Million 16.8%

% of portfolio

0.3%

Previous 0.29%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $439,345 - $500,592	-2,749 Reduced 0.6%	453,514 $82.6 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $1.18 Million - $1.33 Million	-8,572 Reduced 1.84%	456,263 $70.7 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $1.01 Million - $1.17 Million	-7,542 Reduced 1.6%	464,835 $69.3 Million
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $836,270 - $1.04 Million	6,311 Added 1.35%	472,377 $63.6 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $336,507 - $387,538	2,327 Added 0.5%	466,066 $74.3 Million

Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $1.33 Million - $1.59 Million	-9,592 Reduced 2.03%	463,739 $75 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $1.54 Million - $1.77 Million	-11,506 Reduced 2.37%	473,331 $63.5 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $1.89 Million - $2.41 Million	-13,765 Reduced 2.76%	484,837 $74.3 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $1.87 Million - $2.33 Million	-14,205 Reduced 2.77%	498,602 $80.8 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $342,916 - $433,888	-3,192 Reduced 0.62%	512,807 $69.4 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $2.76 Million - $3.14 Million	-25,981 Reduced 4.79%	515,999 $55.7 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $1.1 Million - $1.23 Million	-10,501 Reduced 1.9%	541,980 $61 Million
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $1.15 Million - $1.26 Million	-11,220 Reduced 1.99%	552,481 $59.8 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $172 Million - $232 Million	-2,130,946 Reduced 79.08%	563,701 $60.4 Million
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $39.4 Million - $46.3 Million	-459,158 Reduced 14.56%	2,694,647 $236 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $16.6 Million - $22.2 Million	-226,424 Reduced 6.7%	3,153,805 $310 Million
Q1 2020 May 04, 2020	SELL	$64.5 - $97.79 $75.8 Million - $115 Million	-1,175,771 Reduced 25.81%	3,380,229 $258 Million
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $23.5 Million - $29.4 Million	325,232 Added 7.69%	4,556,000 $403 Million
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $9.54 Million - $11.5 Million	-151,493 Reduced 3.46%	4,230,768 $320 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $19.5 Million - $24.9 Million	-296,589 Reduced 6.34%	4,382,261 $319 Million
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $17.6 Million - $20.7 Million	-228,016 Reduced 4.65%	4,678,850 $377 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $19.4 Million - $24 Million	-249,679 Reduced 4.84%	4,906,866 $452 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $12.9 Million - $14.3 Million	-145,023 Reduced 2.74%	5,156,545 $488 Million
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $21 Million - $24.9 Million	-234,339 Reduced 4.23%	5,301,568 $491 Million
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $5.61 Million - $7.51 Million	-60,939 Reduced 1.09%	5,535,907 $524 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $192 Million - $210 Million	-2,141,066 Reduced 27.67%	5,596,846 $541 Million
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $540 Million - $690 Million	7,737,912	7,737,912 $688 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Abb Vie Inc. Transaction History